LEON D BLACK, an insider at $APO, sold 498,071 shares of the company on 03-19-2025 for an estimated $70,726,082. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.4% of their shares of this class of stock. Following this trade, they now own 34,606,702 shares of this class of $APO stock.
$APO Insider Trading Activity
$APO insiders have traded $APO stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.
Here’s a breakdown of recent trading of $APO stock by insiders over the last 6 months:
- LEON D BLACK has made 0 purchases and 20 sales selling 1,500,000 shares for an estimated $244,478,027.
- JAMES C ZELTER (Co-President (See Remarks)) has made 0 purchases and 15 sales selling 500,000 shares for an estimated $86,950,874.
- SCOTT KLEINMAN (Co-President (See Remarks)) has made 0 purchases and 14 sales selling 500,000 shares for an estimated $86,835,230.
- MARTIN KELLY (Chief Financial Officer) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $3,391,062.
- WHITNEY CHATTERJEE (Chief Legal Officer) has made 0 purchases and 2 sales selling 6,200 shares for an estimated $1,074,851.
- LOUIS-JACQUES TANGUY (Chief Acct. Off. & Controller) sold 2,500 shares for an estimated $441,250
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APO Hedge Fund Activity
We have seen 590 institutional investors add shares of $APO stock to their portfolio, and 446 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 10,750,494 shares (+45.7%) to their portfolio in Q4 2024, for an estimated $1,775,551,589
- STATE STREET CORP added 8,187,700 shares (+77.4%) to their portfolio in Q4 2024, for an estimated $1,352,280,532
- MILLENNIUM MANAGEMENT LLC removed 4,584,837 shares (-94.7%) from their portfolio in Q4 2024, for an estimated $757,231,678
- GEODE CAPITAL MANAGEMENT, LLC added 3,695,979 shares (+64.6%) to their portfolio in Q4 2024, for an estimated $610,427,891
- VANGUARD GROUP INC added 3,691,700 shares (+8.9%) to their portfolio in Q4 2024, for an estimated $609,721,172
- FRANKLIN RESOURCES INC removed 3,538,160 shares (-29.6%) from their portfolio in Q4 2024, for an estimated $584,362,505
- JPMORGAN CHASE & CO added 2,825,061 shares (+151.5%) to their portfolio in Q4 2024, for an estimated $466,587,074
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$APO Analyst Ratings
Wall Street analysts have issued reports on $APO in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 12/19/2024
- Piper Sandler issued a "Overweight" rating on 12/09/2024
- Keefe, Bruyette & Woods issued a "Outperform" rating on 11/06/2024
- Barclays issued a "Overweight" rating on 10/07/2024
- Goldman Sachs issued a "Buy" rating on 10/03/2024
- Evercore ISI issued a "Outperform" rating on 10/02/2024
- Wells Fargo issued a "Overweight" rating on 10/02/2024
To track analyst ratings and price targets for $APO, check out Quiver Quantitative's $APO forecast page.
$APO Price Targets
Multiple analysts have issued price targets for $APO recently. We have seen 7 analysts offer price targets for $APO in the last 6 months, with a median target of $157.0.
Here are some recent targets:
- John Barnidge from Piper Sandler set a target price of $188.0 on 12/09/2024
- Etinenne Ricard from BMO Capital set a target price of $157.0 on 11/06/2024
- Michael Brown from Wells Fargo set a target price of $164.0 on 11/06/2024
- Glenn Schorr from Evercore ISI set a target price of $174.0 on 11/06/2024
- Brian Bedell from Deutsche Bank set a target price of $155.0 on 11/06/2024
- Alexander Blostein from Goldman Sachs set a target price of $135.0 on 10/03/2024
- Steven Chubak from Wolfe Research set a target price of $139.0 on 09/24/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
